Catalyst Wire Dossier Catalyst Wire Dossier

Indacaterol maleate / glycopyrronium bromide

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Indacaterol maleate / glycopyrronium bromide, covering 2015-06-09 to 2018-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients. [Phase 3]

See pricing